Target intelligence / Profile preview

CCAAT-box regulatory DNA element (CCAAT box)

Target
CCAAT box
Molecular classification
DNA regulatory element, Chromatin
01

Overview

The CCAAT-box regulatory DNA element, often identified by its reverse-complement sequence ATTGG, is a highly conserved cis-acting motif located in the proximal promoters of approximately 25-30% of eukaryotic genes (Mantovani, 1999). This site serves as the primary binding target for the heterotrimeric transcription factor Nuclear Factor Y (NF-Y), which acts as a pioneer factor to modulate chromatin accessibility and facilitate the recruitment of the basal transcription machinery (Petroni et al., 2017). These regulatory regions are critical for the expression of genes governing the cell cycle, DNA synthesis, and metabolic pathways, such as Cyclin B1 and Topoisomerase II alpha (Dolfini et al., 2012). In various malignancies, the over-activation or increased accessibility of ATTGG-containing regions drives oncogenic gene expression programs, contributing to tumor proliferation and survival (Gurtner et al., 2003). Therapeutic strategies targeting these DNA regions involve small molecules like Mithramycin A and its analogues, which bind to the DNA minor groove to sterically hinder NF-Y binding and suppress the transcription of its target oncogenes (Gurtner et al., 2003). However, the ubiquitous presence of the CCAAT motif across the genome poses significant challenges, including potential systemic toxicity and the inhibition of essential housekeeping genes in healthy tissues (Petroni et al., 2017).

Other names
ATTGG-containing regulatory regionNF-Y binding siteCCAAT elementNuclear Factor Y binding siteCBF binding site
02

Mechanism of action

DNA minor groove binding and competitive displacement of transcription factors

03

Biological functions

Transcription regulationCell cycle controlChromatin remodelingTranscription initiation
04

Disease associations

CancerBreast cancerColorectal cancerLeukemiaProstate cancer
05

Safety considerations

Systemic toxicityHepatotoxicityThrombocytopeniaOff-target transcriptional suppression of essential genes
06

Interacting drugs

Mithramycin A

3 more in the full profile.

07

Biomarkers

NF-YA expressionCyclin B1 (CCNB1) levelsCDC25C expressionTopoisomerase II alpha levels

Beyond the preview

Go deeper on CCAAT-box regulatory DNA element (CCAAT box).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCAAT-box regulatory DNA element (CCAAT box).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call